1. Market Research
  2. > Healthcare Market Trends
  3. > Patient-Centric Mobile Apps: Key Opportunities and Challenges for Pharma




Dozens of new health apps for smartphones and tablets are produced monthly. Hundreds of thousands already exist. What does it take for a patient app to stand out in this crowded space? What are the essential ingredients that differentiate an app for patients…and for pharma?


A well-designed app has the potential to increase the quality and efficiency of healthcare, to empower patients to manage their health better, and to deliver an experience patients will remember. Getting apps right is critical if Pharma is to successfully transform itself into a truly patient-centered business.


Patient-centric Mobile Apps: Key Opportunities and Challenges for Pharma gives you the information you need to understand what patients, healthcare providers and other stakeholders want in a healthcare app — and how a successful one promotes health outcomes and positive customer experiences.







Answers to Key Questions

How can pharma leverage apps to improve relationships with patients?

What does it take for healthcare providers to become advocates of your app?

What are the essential elements of a successful patient-centric healthcare app?

What types of apps are most widely recommended to patients by healthcare providers, and how do these apps augment patient care?



Key Issues Explored

Capturing and leveraging the real-world data that apps generate

Building and managing the 24/7 relationship with customers and patients through apps

Critical success factors for patient apps

How to measure and demonstrate ROI of patient apps

The future of patient apps and pharma’s evolving role


Top Takeaways

Your next partner could be a tech giant
Customer experience is now part of your job description, and you need to ace it
Healthcare apps are effectively medical devices and could be at risk for increased regulatory scrutiny
Longevity of the patient relationship will drive future app development
Learn what the customer needs before designing an app
Pharma must keep challenging itself to align communications and engagement strategies with the multichannel options available



Expert Contributors

Helena Binder, Communications Director, European Patient Panel
Michael Bodenstab, Vice President, Healthcare Solutions, Physicians Interactive
Neil Chandler, Vice President Commercial Excellence, Daiichi Sankyo
Jeremy Dalnes, Worldwide Director, Digital Strategy and Platforms, J&J
Flourent Edouard, Vice President, Commercial Excellence, AstraZeneca
Leigh Hope, Senior Product Manager, Novo Nordisk
Richard Evans, Founding Director, NexGen Healthcare
Rod Fernandez-Baca, Business Unit Director, Gilead
David Gillen, Head Patient Safety, Celgene
Helen Harrison, Digital Director, EMEA, Lilly
Dr Roger Henderson, General Practitioner, UK
Wills Hughes-Wilson, Chief Patient Access Officer, Sobi
Matt Jamieson-Evans, HealthUnlocked
Christine Jordens, Business Support Team Leader, Boehringer Ingelheim
Bernard Levy, Operations Director, Oncology, Roche
Christian Lindknud, Business Manager, Fujirebio
Dr Graeme Moyle, Director of Clinical Trials, Chelsea & Westminster Hospital
Dr Ali Parsa, CEO, Babylon Health
Rebecca Reeve, Head of KOL Relationships, UK & Ireland, Sanofi
Benjamin Tilly, Multichannel Marketing Lead, UK & Ireland, GSK





About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence



FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.


Table Of Contents

Patient-Centric Mobile Apps: Key Opportunities and Challenges for Pharma
Content Highlights

1.The rise of and reasons for health telematics

1.1.to patient-centric medicine
1.2.Mobile health is the new normal
1.3.Patient-centricity is facilitated through smart patients using smartphones
2.How patients use apps

2.1.ROI is determined differently between patients and pharma
2.2.Components, functionality and use: the essential elements of apps
2.3.Co-creating apps with patients: entrepreneurs and collaboration with organisations
3.4.CASE STUDY: ManAge

3.The value of apps for general healthcare providers

3.1.The consumer patient: health apps
3..2App use by governmental organisations - public health, epidemiology and resource 3.3economies
3.4.4App use by patient organisations

4.How the pharmaceutical industry views apps

4.1.Strategy, sales tool or service?
4.2.An early rush to create apps has left mixed opinions about industry's intentions
4.3.Longevity of the patient relationship will drive future app development


5.The use and value of apps by HCPs

5.1.Digital native or traditional physician: app confidence and use
5.2.Augmenting patient care with apps
5.3.CASE STUDY: SERMO - A crowdsourcing app to expedite clinical diagnosis


6.The future for app development and use

6.1.Generating real-world data for real-world solutions
6.2.Regulation: roles of regulatory and medical organisations
6.3.Competitive collaboration within pharma

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Virology and Bacteriology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales and Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

2016 Infectious Disease Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Microbiology Tests, Technology Trends, Opportunities for Suppliers

  • $ 54501
  • Industry report
  • October 2016
  • by Venture Planning Group

This unique 33-country survey from VPGMarketResearch.com contains over 2,100 pages, 875 tables and provides data and analysis not available from any other published source. The survey is designed to assist ...

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

2016 Microbiology Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Molecular Diagnostic, Microbial Identification, Antibiotic Susceptibility, Blood Culture, Urine Screening, and Immunodiagnostic Tests

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,000 pages and 550 tables, and provides granular data and analysis not available from any other published source. The survey is designed ...


Download Unlimited Documents from Trusted Public Sources

Public Health Industry in the UK - Forecast

  • December 2016
    60 pages
  • Public Health  

  • United Kingdom  

    Europe  

View report >

Public Health Industry in the UK

  • December 2016
    156 pages
  • Public Health  

    Neurological Di...  

    Hospital  

  • United Kingdom  

View report >

Biopsy Industry in the Netherlands

  • December 2016
    10 pages
  • Biopsy  

  • Netherlands  

View report >

Hospital Industry

2 days ago

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.